共 252 条
[1]
Chang MY(2007)Factors predicting poor survival after resection of stage IA non-small cell lung cancer J Thorac Cardiovasc Surg 134 850-856
[2]
Mentzer SJ(2007)Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib J Clin Oncol 25 2528-2533
[3]
Colson YL(2005)Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib J Clin Oncol 23 5900-5909
[4]
Linden PA(1999)The epidemiology of lung cancer Ann Oncol 10 S3-S6
[5]
Jaklitsch MT(1999)Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas J Clin Oncol 17 2086-2091
[6]
Lipsitz SR(2005)Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study Lung Cancer 50 227-234
[7]
Sugarbaker DJ(2005)Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib J Clin Oncol 23 2493-2501
[8]
Cho BC(2004)High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan Clin Cancer Res 10 8195-8203
[9]
Im CK(2005)Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer—a multicenter study Lung Cancer 49 63-70
[10]
Park MS(2008)Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung J Thorac Oncol 3 704-710